Dry Eye Disease

scientific article published on 01 September 2015

Dry Eye Disease is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.1097/OPX.0000000000000681
P698PubMed publication ID26301366

P50authorPenny AsbellQ43109114
P2093author name stringJason J Nichols
Kelly K Nichols
Meng C Lin
Kenneth A Polse
Todd Margolis
Nancy A McNamarra
P433issue9
P921main subjecteye diseaseQ3041498
P304page(s)922-924
P577publication date2015-09-01
P1433published inOptometry and Vision ScienceQ15716649
P1476titleDry Eye Disease
P478volume92

Reverse relations

cites work (P2860)
Q33837188A novel TRPM8 agonist relieves dry eye discomfort
Q47138569TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.

main subject (P921)
Q64071011A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers
Q64271792A review of functional slit lamp biomicroscopy
Q64246027Air Pollutants are associated with Dry Eye Disease in Urban Ophthalmic Outpatients: a Prevalence Study in China
Q64080422Comparison of the meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease and Sjögren's syndrome
Q61815399Differential Bacterial Colonization and Biofilm Formation on Punctal Occluders
Q64244569Discrepancies in Persistent Dry Eye Signs and Symptoms in Bilateral Pseudophakic Patients
Q64060184Dry Eye Disease: Consideration for Women's Health
Q64099037Dry eye disease immune responses and topical therapy
Q61799655Gout as a Risk Factor for Dry Eye Disease: A Population-Based Cohort Study
Q64134659Impacts of air pollution on dry eye disease among residents in Hangzhou, China: A case-crossover study
Q64244731Prevalence and Determinants of Dry Eye Disease among 40 Years and Older Population of Riyadh (Except Capital), Saudi Arabia
Q64249310Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease
Q61811564TearCare system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare treatment on subjects with dry eye disease
Q64106481Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development

Search more.